Court restricts abortion access across US by blocking mailing of mifepristone
A federal appeals court has restricted access to mifepristone, a common abortion medication, by blocking its mailing across the U.S. The 5th U.S. Circuit Court of Appeals ruled that the drug must now be distributed in person at clinics. This decision impacts abortion and miscarriage care nationwide, particularly affecting vulnerable populations who rely on telemedicine.
- ▪The 5th U.S. Circuit Court of Appeals requires mifepristone to be distributed only in person at clinics.
- ▪The ruling challenges access to abortion via telemedicine, which became a major method after the 2022 overturning of Roe v. Wade.
- ▪Louisiana's argument that unborn children are legal persons from conception influenced the court's decision.
- ▪The ACLU warns that restricting telemedicine access disproportionately harms rural communities, low-income individuals, people with disabilities, and communities of color.
Opening excerpt (first ~120 words) tap to expand
ABC NewsLiveVideoShowsGood Morning AmericaShopGMAInterest Successfully AddedWe'll notify you here with news aboutTurn on desktop notifications for breaking stories about interest? OffOnStream onCourt restricts abortion access across US by blocking mailing of mifepristoneA federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristoneByThe Associated PressMay 1, 2026, 5:56 PM1:55FILE - Mifepristone tablets sit on a table at a Planned Parenthood clinic in Ames, Iowa, July 18, 2024. (AP Photo/Charlie Neibergall, File)The Associated PressNEW ORLEANS -- A federal appeals court has restricted access to one of the most common means of abortion in the U.S.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at ABC News — Top.
Discussion
0 commentsMore from ABC News — Top
